Zanidip®-Recordati (Zanidip®-Recordati)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceLercanidipineLercanidipine
Similar drugsTo uncover
  • Zanidip®-Recordati
    pills inwards 
    RECORDATA Ireland Co., Ltd.     Ireland
  • Lercamen® 10
    pills inwards 
    Berlin-Chemie, AG / Menaryini Group     Germany
  • Lercamen® 20
    pills inwards 
    Berlin-Chemie / A. Menarini, LLC     Russia
  • Lercanidipine-SZ
    pills inwards 
    NORTH STAR, CJSC     Russia
  • Lercanorm
    pills inwards 
    VERTEKS, AO     Russia
  • Lernikor®
    pills inwards 
    OBOLENSKOE PHARMACEUTICAL ENTERPRISE, CJSC     Russia
    • Dosage form: & nbspfilm-coated tablets
    Pharmacotherapeutic group:The blocker of slow calcium channels
    ATX: & nbsp

    C.08.C.A   Dihydropyridine derivatives

    C.08.C.A.13   Lercanidipine

    Form release / dosage:Tablets, film-coated 10 mg, 20 mg.
    Packaging:10 mg: (28) - blister (1) / For 28 tablets in a blister of opaque PVC film / aluminum foil. 1 blister with instructions for use in a cardboard package. / - Cardboard tutu

    20 mg: (28) - blister (1) / For 28 tablets in a blister of an opaque PVC film / aluminum foil. 1 blister with instructions for use in a cardboard package. / - Cardboard tutu

    Storage conditions:At a temperature not higher than 30 ºะก Keep out of the reach of children.
    Shelf life:3 grams
    Terms of leave from pharmacies:On prescription
    Registration number:LP-000705
    Date of registration:28.09.2011
    The owner of the registration certificate:RECORDATA Ireland Co., Ltd.RECORDATA Ireland Co., Ltd. Ireland
    Manufacturer: & nbsp
    Representation: & nbspRECORDINGS RECORDINGS Italy
    Information update date: & nbsp13.11.2015
    Illustrated instructions
      Instructions
      Up